Decoding India’s Section 3(d) Pharma Controversy

India owns the third largest pharmaceutical industry in the world in terms of volume and is the 14th largest in terms of value. It has joined hands with those of China, Brazil, Russia and 13 other countries to create a pool of pharmerging countries. This pool is expected to contribute nearly 50% of the world’s annual pharmaceutical market growth. While India has grown dramatically in the supply of generic medicines, until 1995 the country did not allow patenting of product inventions in pharma. Read more [...]
Dr. Nalini Mohan Koutha
Dr. Nalini Mohan Koutha

Dr. Nalini is a Pharmaceutical patent expert and has extensive experience as a technical and Intellectual Property Specialist in Generic Pharmaceutical manufacturing. His quest for analytical thinking extends to his deep interest in philately.


2 Comments

Post a Comment

Your email address will not be published. Required fields are marked *